0001437749-23-016002.txt : 20230526
0001437749-23-016002.hdr.sgml : 20230526
20230526171624
ACCESSION NUMBER: 0001437749-23-016002
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230525
FILED AS OF DATE: 20230526
DATE AS OF CHANGE: 20230526
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Climaco John M
CENTRAL INDEX KEY: 0001546797
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37758
FILM NUMBER: 23970300
MAIL ADDRESS:
STREET 1: PO BOX 326
CITY: PARK CITY
STATE: UT
ZIP: 84060
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Moleculin Biotech, Inc.
CENTRAL INDEX KEY: 0001659617
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 474671999
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5300 MEMORIAL DRIVE
STREET 2: SUITE 950
CITY: HOUSTON
STATE: TX
ZIP: 77007
BUSINESS PHONE: 713-300-5160
MAIL ADDRESS:
STREET 1: 5300 MEMORIAL DRIVE
STREET 2: SUITE 950
CITY: HOUSTON
STATE: TX
ZIP: 77007
4
1
rdgdoc.xml
FORM 4
X0407
4
2023-05-25
0001659617
Moleculin Biotech, Inc.
MBRX
0001546797
Climaco John M
C/O MOLECULIN BIOTECH, INC.
5300 MEMORIAL DR., SUITE 950
HOUSTON
TX
77007
1
0
Stock option (right to buy)
0.62
2023-05-25
4
A
0
15000
A
2033-05-25
Common Stock
15000
77501
D
The options set forth in this table vest on the earlier of one year from the date of the Company's 2023 annual meeting of stockholders or on the next annual meeting of stockholders, subject to the grantee's continued service on the Company's Board of Directors on such vesting date.
The options were issued in connection with the reporting person's Board of Director service to the Company.
/s/ Jonathan Foster by Power of Attorney
2023-05-26